Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | pUMVC3-hIGFBP-2 vaccine |
Trade Name | |
Synonyms | AST 201|AST201 |
Drug Descriptions |
pUMVC3-hIGFBP-2 vaccine (AST-201) is a DNA vaccine engineered to encode human insulin-like growth factor-binding protein 2 (hIGFBP-2) epitopes, which may stimulate anti-tumor immunity (PMID: 34526360). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C95727 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Paclitaxel + pUMVC3-hIGFBP-2 vaccine + Sargramostim | Carboplatin Paclitaxel Sargramostim pUMVC3-hIGFBP-2 vaccine | 0 | 1 |
pUMVC3-hIGFBP-2 vaccine | pUMVC3-hIGFBP-2 vaccine | 0 | 0 |